Impact of EGCG Supplementation on the Progression of Diabetic

Aug 21, 2017 - Although, a number of potential treatment strategies exist for diabetic nephropathy, considering the ease of use and bioavailability, p...
0 downloads 7 Views 2MB Size
Subscriber access provided by Kent State University Libraries

Article

IMPACT OF EGCG SUPPLEMENTATION ON THE PROGRESSION OF DIABETIC NEPHROPATHY IN RATS: AN INSIGHT INTO FIBROSIS AND APOPTOSIS Kalaiselvi Periandavan, Thangarajeswari Mohan, Prema Velusamy, Lakshmi Narasimhan Chakrapani, Ashok Kumar Srinivasan, Abhilasha Singh, and Thanka Johnson J. Agric. Food Chem., Just Accepted Manuscript • Publication Date (Web): 21 Aug 2017 Downloaded from http://pubs.acs.org on August 21, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 34

Journal of Agricultural and Food Chemistry

1

IMPACT OF EGCG SUPPLEMENTATION ON THE PROGRESSION OF

2

DIABETIC NEPHROPATHY IN RATS: AN INSIGHT INTO FIBROSIS AND

3

APOPTOSIS

4 5 6 7 8 9

Thangarajeswari Mohan1, Prema Velusamy1, Lakshmi Narasimhan Chakrapani1, Ashok Kumar Srinivasan1, Abhilasha Singh1, Thanka Johnson2, Kalaiselvi Periandavan1*

10 11

1

Department of Medical Biochemistry, Dr.ALMPGIBMS, University of Madras, Taramani Campus, Chennai. 2 Department of Pathology, Sri Ramachandra University, Chennai.

*-Corresponding author Abstract

12

Apoptosis is an active response of cells to altered microenvironments which is

13

characterized by cell shrinkage, chromatin condensation and DNA fragmentation, in variety

14

of cell types such as renal epithelial cells, endothelial cells, mesangial cells and podocytes.

15

Hyperglycemia is among the micro environmental factors that may facilitate apoptosis which

16

plays a decisive role in the initiation of diabetic nephropathy. Transforming growth factor-β,

17

emerges as a powerful fibrogenic factor in the development of renal hypertrophy. Although, a

18

number of potential treatment strategies exist for diabetic nephropathy, considering the ease

19

of use and bioavailability, phytochemicals stands distinct as the preeminent option. EGCG, a

20

green tea catechin is one such phytochemical which possess hypoglycemic and anti-fibrotic

21

activity. The present study aims to explore the potential of EGCG to prevent apoptosis in

22

high-fat diet and STZ induced diabetic nephropathy rats by assessing renal function, pro-

23

fibrotic marker, and the expression of apoptotic and anti-apoptotic proteins. Our results

24

validate EGCG as a potential anti-apoptotic agent evidently by improving renal function via

25

down regulating TGF-β, consequently ameliorating diabetic nephropathy. In accordance,

26

EGCG might be regarded as a prospective therapeutic candidate in modulating diabetic

27

nephropathy, thus being a promising treatment.

28

Key words: Diabetic nephropathy, EGCG, High-fat diet, STZ, TGF-β, Apoptosis.

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

29

Introduction

30

Apoptosis contributes to the development of diabetic nephropathy leading to the

31

functional deterioration of the kidney. Epithelial cells, endothelial cells, mesangial cells and

32

podocytes play a crucial role in the maintenance of structure and function of the glomerulus.

33

Injury to the glomerulus is usually characterized by effacement of foot processes leading to

34

proteinuria,1 accumulation of extracellular matrix, mesangial matrix expansion, and tubular

35

fibrosis.

36

Transforming growth factor-β (TGF-β) is shown to induce podocyte loss via apoptosis

37

in diabetic nephropathy contributing to the development of glomerulosclerosis2 and regulate

38

urinary albumin excretion by increasing both glomerular permeability and decreasing

39

reabsorption in the proximal tubules.3 Even though, a number of potential treatment strategies

40

have shown benefit in improving surrogate markers like albuminuria, but the translation to

41

preserve GFR and prevent ESRD has not always been followed.4

42

Therefore, any phytochemical that addresses glycemic control, podocytes loss by

43

preventing apoptosis and regulate TGF-β levels will be a promising therapeutic agent that

44

targets diabetic nephropathy. EGCG (Epigallocatechin-3-gallate) is shown to possess anti-

45

hyperglycemic effect5,6 and anti-fibrotic effect,7,8 also has an afforded protective effect

46

against ROS production in diabetic nephropathy induced mice kidneys.9 Therefore, we

47

intended to investigate the role of EGCG in ameliorating apoptosis in the kidneys of rats

48

induced with diabetic nephropathy.

49

Materials and Methods

50

Chemicals

51

Epigallocatechin-3-gallate and Bovine Serum Albumin were procured from Sigma–

52

Aldrich, USA. Streptozotocin (STZ) was purchased from Cayman chemicals, Europe. All

53

other chemicals used were of analytical grade and were obtained from SRL (Sisco Research

ACS Paragon Plus Environment

Page 2 of 34

Page 3 of 34

Journal of Agricultural and Food Chemistry

54

Laboratories Pvt. Ltd) and CDH (Central Drug House Pvt. Ltd., Mumbai, India). Enhanced

55

chemiluminescence (ECL) kit was purchased from BioRad, USA.

56

Laboratory animals

57

Male albino rats of Wistar strain (100-110g) were obtained from Central Animal

58

House facility, University of Madras, Taramani campus, and experiments were conducted in

59

accordance with guidelines approved by the Institutional Animal Ethical Committee (IAEC

60

No.

61

conditions of controlled temperature (25±2 °C) with 12/12 h light/dark cycle and were given

62

food and water ad libitum. The animals were maintained on a commercial rat feed

63

manufactured by Hindustan Lever Ltd., Mumbai under the trade name “GOLD MOHUR

64

RAT FEED”. The feed contained 5% fat, 21% protein, 55% nitrogen free extract, 4% fibre

65

(w/w) with adequate vitamins and minerals.

66

Experimental design

67

01/07/2016). The animals were housed two per cage in large spacious cages under

Diabetic nephropathy model was established by High-fat Diet (HFD) comprising of

68

the normal rat chow

69

30% coconut oil and 30% fructose water. After sixty days of dietary manipulation, HFD fed

70

rats was injected intraperitoneally (i.p.) with low dose of streptozotocin (STZ, 30 mg/kg,

71

Cayman chemicals, Europe) dissolved in 0.1 M citrate buffer, pH 4.3. The fasting blood

72

glucose was measured 3 days after the STZ injection. Rats with the fasting blood glucose

73

16.7 mmol/L and above were considered as diabetic rats. Then these rats are left for fortnight

74

to establish diabetic nephropathy and allowed to continue to feed on their respective diets

75

until the end of the study.

supplemented with 4% cholesterol and 1.5% cholic acid along with

76

Group 1: Normal control rats were given saline orally for 28 days. Group 2:

77

Diabetic nephropathy induced HFD fed rats. Group 3: Diabetic nephropathy induced HFD

78

fed rats treated with EGCG (100mg/kg body weight) through oral gavage for 28 days. Group

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

Page 4 of 34

79

4: Rats were treated with EGCG (100mg/kg body weight) through oral gavage for 28 days.

80

Urine was collected from the rats housed in metabolic cages for 24hr. (Based on the literature

81

survey, bioavailability of EGCG is about 1.6% accounting to approximately 320µg for a rat

82

weighing 200 g).

83

At the end of the experimental period, rats were anesthetized with ketamine (22

84

mg/kg body weight, i/p) and kidneys were excised immediately, immersed in ice-cold

85

physiological saline and 10% cortex of the kidney tissue homogenate were prepared using

86

Tris-HCl buffer (0.01 M, pH 7.4), followed by centrifugation at 12,000 rpm for 10 min and

87

the supernatant was used for the analysis of various parameters. Rest of the tissue was stored

88

at -80oC for protein expression studies. For histological examination, the kidney was

89

collected and fixed in 10 % neutral buffered formalin, embedded in paraffin. Standard

90

sections of 5 μm thickness were cut, which were then stained with hematoxylin and eosin

91

(H&E) and Masson Trichrome Stains.

92

Fasting blood glucose measurements

93

Fasting blood glucose levels were measured weekly on lateral tail vein blood samples TM

94

using an One touch select simple

95

treatment period.

96

Determination of glycosylated hemoglobin (HbA1c)

97

Glycosylated

hemoglobin

meter and system (Life scan, Scotland) throughout the

was

assessed

using

the

Hemoglobin

Analyzer

98

(D-10 - Biorad) based on chromatographic separation of the analytes by ion exchange high

99

performance liquid chromatography (HPLC) and the changes in the absorbance measured at

100

415 nm.

101

Urinary parameter

102

The 24 h urine sample collected from each rat was centrifuged and the supernatant

103

was used for further analysis. Creatinine levels were determined using Kit method

ACS Paragon Plus Environment

Page 5 of 34

Journal of Agricultural and Food Chemistry

104

(Medsource Ozane Biomedicals). Glomerular Filtration Rate (GFR) was calculated on the

105

basis of urinary creatinine, serum creatinine and urine volume using the following equation:

106

GFR (mL/min) = [urinary creatinine (mg/dl × urine volume (mL)/serum creatinine (mg/dl)]

107

×1/1440 (min)]. Albumin creatinine ratio (ACR) was calculated from the urinary creatinine

108

and urinary albumin values.

109

Assay of urinary albumin by ELISA

110

Urinary proteins were extracted using 10% TCA and High affinity 96 well microtitre

111

plates were coated with 10 µg of protein in 50µl of 0.2 M sodium carbonate/bicarbonate

112

buffer (pH 9.6) per well and incubated at 4°C for overnight. After that plates were washed

113

thrice with 100 µl of 0.01M phosphate buffered saline (pH 7.4) and then blocked for 2 hours

114

with 200 µl of 1% BSA in PBS at 37°C. Following four washes as above in PBS, appropriate

115

primary antibody diluted in PBS were added and incubated at 4°C for overnight. Further,

116

plates were washed thrice with phosphate buffered saline (pH 7.4) in 0.2 % Tween 20 (PBS-

117

T) and incubated with 100 µl of streptavidin-horse radish peroxidase for 1 hour.

118

Subsequently after washing, the reaction was visualized by the addition of 100µl/well 2,2’

119

Azinobis [3-ethylbenzothiazoline-6sulfonic acid] diammonium salts (ABTS) substrate for

120

20min at room temperature. The reaction was stopped by the addition of 100µl/well 2N

121

H2SO4 optical densities were determined at 415 nm using iMark™ Microplate Absorbance

122

Reader (Biorad). The urinary albumin was expressed as ng/mL. 10

123

Analysis of serum lipid profile

124

Total Cholesterol, Triglycerides and High density lipoproteins (HDL) in serum were

125

analyzed using commercial kits from Spin react in the auto analyzer (Rx Monza, Randox,

126

U.K). The values of total cholesterol, triglycerides, LDL (Low Density Lipoprotein), VLDL

127

(Very Low Density Lipoprotein) and HDL are expressed as mg/dl.

128

Biochemical analysis of protein carbonyl and lipid peroxidation in kidney cortex tissue

ACS Paragon Plus Environment

Journal of Agricultural and Food Chemistry

129

The estimation of protein carbonyl in kidney cortex tissue were determined

130

using 2, 4-dinitrophenyl hydrazine (DNPH) with slight modifications of the method of

131

Levine et al.,11 and expressed as nmoles of protein carbonyl/mg protein/ml.

132

The level of lipid peroxides was assayed by the method of Devasagayam and

133

Tarachand, 12 and expressed as nmoles of MDA released/g of tissue.

134

Western blot analysis

135

Cortical kidney tissue samples were homogenized in Tris-HCl buffer (0.01 M, pH

136

7.4) and protein concentrations were determined.13 For immunoblotting, aliquots of lysate

137

were mixed with loading buffer containing dithiothreitol and maintained at 95oC for 10 min

138

before loading on 10% SDS-PAGE. Following SDS-PAGE separation, proteins were

139

transferred to polyvinyl difluoride membrane (PVDF). Membranes were blocked in Tris-

140

buffered saline with Tween-20 containing 5% (w/v) non-fat milk for 1 h at room temperature.

141

Membrane strips were incubated with primary antibodies (TGF-β1, Bax, Bcl-2 and cleaved

142

caspase-3) overnight at 4oC. Following extensive washing, membrane strips were incubated

143

with horseradish peroxidase conjugated secondary antibodies for 1 h. Protein bands were

144

detected by the detection reagent mixture (an equal volume of luminol with H2O2) using

145

standard enhanced chemiluminescence method in Bio-rad Chemidoc XRS imaging system.

146

Statistical analysis

147

Data are presented as mean ± Standard Error of Mean (SEM) of the results obtained

148

from the average of at least three or six independent experiments. Differences between

149

groups were analyzed by one-way analysis of variance (ANOVA) using the SPSS software

150

package for Windows (Version: SPSS 20.0). Post hoc testing was performed for inter-group

151

comparisons using Least Significant Difference (LSD) test. Values are statistically significant

152

at the level of p